Author

V. Martins

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Assay:behavioral assay· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:rat· 1

Frequent Co-Authors

A. M. Sebastiao· 1 shared A. Martinez-Marquez· 1 shared A. Shah· 1 shared B. de Alves Pereira· 1 shared C. Latimer· 1 shared C. McCann· 1 shared C. Miranda-Lourenco· 1 shared D. B. Longley· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. M. Sebastiao

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The grapevine ABC transporter B family member 15 (VvABCB15) is trans-resveratrol transporter out of grapevine cells

A. Martinez-Marquez, V. Martins, S. Selles-Marchart, H. V. Geros, P. Corchete, R. Bru-Martinez

The paper identifies VvABCB15 as a trans-resveratrol transporter in grapevine cells through functional characterization in heterologous systems and localization studies.

bioRxiv · Oct 20, 2023 · PreprintPlant Biology

Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior

M. Farinha-Ferreira, N. Rei, J. Fonseca-Gomes, C. Miranda-Lourenco, P. Serrão, S. H. Vaz, J. I. Gomes, V. Martins, B. de Alves Pereira, A. M. Sebastiao

This study investigates the effects of chronic adolescent HU-210 exposure on emotional behavior, finding no long-term depressive-like effects but short-term stress-induced reactivity changes.

bioRxiv · Dec 13, 2021Pharmacology & Toxicology

Clinical positioning of the IAP antagonist tolinapant (ASTX660) in colorectal cancer

D. B. Longley, N. T. Crawford, K. J. Stott, T. Sessler, C. McCann, W. McDaid, C. Latimer, J. Fox, J. M. Munck, T. Smyth, A. Shah, V. Martins, M. Lawler, P. D. Dunne, E. M. Kerr, , V. M. Coyle

This study shows tolinapant, an IAP inhibitor, enhances chemotherapy-induced apoptosis in colorectal cancer by modulating FLIP and HDACs, suggesting its clinical use in poor prognosis MSS CRC with elevated cIAP1/2.

bioRxiv · Nov 20, 2020Cancer Biology